FDA Drug Application (022299) for NEVIRAPINE TABLETS FOR ORAL SUSPENSION by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number022299
Product Number001
FormTABLET; ORAL
Dosage50MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNEVIRAPINE TABLETS FOR ORAL SUSPENSION
Active IngredientNEVIRAPINE



Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.